Eva Martin, M.D., is a passionate advocate for innovation for patients. She received her undergraduate degree in Social and Cognitive Neuroscience from Harvard College. Prior to medical school, Dr. Martin worked at the University of California, San Francisco conducting breast cancer research. She received her medical degree from Harvard Medical School. After her Obstetrics and Gynecology internship training at Kaiser Permanente San Francisco, Dr. Martin founded a women’s health medical device company and developed a novel medical device for use in pregnancy and labor. The device received FDA clearance, a utility patent from the USPTO, and a prestigious US National Institutes of Health research grant.

Dr. Martin joined Roche Diagnostics in 2018 as the Director of Clinical Science for Women’s Health, Sequencing, and subsequently, the Data Strategy Lead – Clinical within the Oncology and Genetics group. At Roche Diagnostics, she was responsible for supporting all stages of diagnostics product development, from pipeline ideation to commercialization. Dr. Martin joined the Pharma Partnering team at Roche Genentech in 2022, and currently serves as Senior Director, Alliance and Asset Management, contributing to meaningful partnerships across the pharmaceutical development lifecycle from target and drug discovery through clinical development and commercialization. At Roche, Dr. Martin is grateful for the opportunity to support product development to meet the needs of patients worldwide.